Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Multiple Myeloma 2Carcinoma in Situ 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Rectal Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Papillomavirus Infections 1Oropharyngeal Neoplasms 1Lymphoma, Follicular 1Leukemia, Hairy Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Burkitt Lymphoma 1Anus Neoplasms 1

Interventions

pembrolizumab 1fludarabine phosphate 1fludarabine 1epigallocatechin gallate 1aldesleukin 1Watchful Waiting 1Transurethral Resection of Prostate 1Transdermal Patch 1Restraint, Physical 1Respiratory Function Tests 1Prochlorperazine 1Positron-Emission Tomography 1Ondansetron 1O(6)-codeine methyl ether 1Nicotine Replacement Therapy 1Molecular Diagnostic Techniques 1Meperidine 1Magnetic Resonance Imaging 1Loperamide 1Interleukin-2 1Innovar 1Indomethacin 1Hydroxyzine 1Human Papillomavirus DNA Tests 1Granisetron 1Focus Groups 1Electrocardiography 1Droperidol 1Doxylamine 1Diphenoxylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Dysplasia × Diphenhydramine × 90 days × Clear all
NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
224 enrolled 15 charts
Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡